Home | Contact Us | Search | Site Map
About Us Technology Products R&D Partners Investors Media Careers Hidden
Crucell
Hansenula polymorpha Technology



  PER.C6® Technology
  Vaccine Technology
  PER.C6® Technology
  AdVac® Technology
  Virosome Technology
  Recombinant Paramyxovirus
  Hansenula polymorpha
  Description
  Applications
  Partnering Opportunities
  Protein Technology

Key Strengths
  • H. polymorpha provides an expression system with superior characteristics for the synthesis of pharmaceutical compounds, including vaccines.

 

  • H. polymorpha provides a safe production platform lacking pyrogens, pathogens or viral inclusions.

 

  • H. polymorpha is easy with regard to genetic manipulation and robust in industrial scale fermentations.

 

  • Several patents covering various components of the system protect the H. polymorpha expression platform.
  E-mail this page   Print this page

    Home  |  Contact Us  |  Search  |  Site Map  |  
MoveNext - Latus © Crucell 2006 | Disclaimer